1. Home
  2. GERN vs THR Comparison

GERN vs THR Comparison

Compare GERN & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GERN
  • THR
  • Stock Information
  • Founded
  • GERN 1990
  • THR 1954
  • Country
  • GERN United States
  • THR United States
  • Employees
  • GERN N/A
  • THR N/A
  • Industry
  • GERN Biotechnology: Pharmaceutical Preparations
  • THR Industrial Machinery/Components
  • Sector
  • GERN Health Care
  • THR Energy
  • Exchange
  • GERN Nasdaq
  • THR Nasdaq
  • Market Cap
  • GERN 823.0M
  • THR 878.9M
  • IPO Year
  • GERN 1996
  • THR 2011
  • Fundamental
  • Price
  • GERN $1.38
  • THR $26.62
  • Analyst Decision
  • GERN Buy
  • THR
  • Analyst Count
  • GERN 7
  • THR 0
  • Target Price
  • GERN $3.17
  • THR N/A
  • AVG Volume (30 Days)
  • GERN 6.7M
  • THR 243.4K
  • Earning Date
  • GERN 11-06-2025
  • THR 11-06-2025
  • Dividend Yield
  • GERN N/A
  • THR N/A
  • EPS Growth
  • GERN N/A
  • THR 9.96
  • EPS
  • GERN N/A
  • THR 1.58
  • Revenue
  • GERN $164,447,000.00
  • THR $491,979,000.00
  • Revenue This Year
  • GERN $175.15
  • THR $2.56
  • Revenue Next Year
  • GERN $56.61
  • THR $6.31
  • P/E Ratio
  • GERN N/A
  • THR $16.80
  • Revenue Growth
  • GERN 11877.20
  • THR N/A
  • 52 Week Low
  • GERN $1.09
  • THR $23.05
  • 52 Week High
  • GERN $4.50
  • THR $33.25
  • Technical
  • Relative Strength Index (RSI)
  • GERN 44.59
  • THR N/A
  • Support Level
  • GERN $1.26
  • THR N/A
  • Resistance Level
  • GERN $1.48
  • THR N/A
  • Average True Range (ATR)
  • GERN 0.07
  • THR 0.00
  • MACD
  • GERN -0.00
  • THR 0.00
  • Stochastic Oscillator
  • GERN 13.64
  • THR 0.00

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

About THR Thermon Group Holdings Inc.

Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.

Share on Social Networks: